Product Information

BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0809 per EA under NDC 00591354160. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Mar 24, 2009. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL SR 150 MG TABLET

bupropion hydrochloride
$0.0809per EA

Strength

150 mg/1

NDC

00591354160

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079095

FDA Approved

3/24/2009

TE Code

AB1

On Market Since

7/2/2009

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 66.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0809 per EA
All-time high$0.2667 (Feb 12, 2014)
All-time low$0.0709 (May 22, 2024)
52-week high$0.0840
52-week low$0.0799
Median price$0.1167
Average price$0.1275
Largest weekly change+20.0% (Jun 19, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+1.3%

3M

-2.4%

6M

-2.6%

1Y

+0.5%

3Y

-3.9%

5Y

-26.7%

All

-66.7%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.0809 per EA (NDC 00591354160), effective Nov 11, 2026.

How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 66.7%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?

Since Nov 28, 2013, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.0709 (May 22, 2024) to a high of $0.2667 (Feb 12, 2014), with a median of $0.1167 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 4% below BUPROPION HCL SR 150 MG TABLET.

Who manufactures BUPROPION HCL SR 150 MG TABLET?

BUPROPION HCL SR 150 MG TABLET (NDC 00591354160) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.